Correction: Real‑world experience with calcitonin gene‑related peptide‑targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers

BMC Neurol. 2024 May 9;24(1):157. doi: 10.1186/s12883-024-03665-5.

Authors

Mamoru Shibata¹, Kazuki Fujita², Eri Hoshino², Kazushi Minami³, Kenzo Koizumi³, Satoshi Okada³, Fumihiko Sakai⁴

Affiliations

¹ Department of Neurology, Tokyo Dental College Ichikawa General Hospital, 5‑11‑13 Sugano, Ichikawa, Chiba, 272‑8513, Japan. mshibata@tdc.ac.jp.
² Saitama International Headache Center, Saitama Neuropsychiatric Institute, Saitama, Japan.
³ Department of Neurology, Tokyo Dental College Ichikawa General Hospital, 5‑11‑13 Sugano, Ichikawa, Chiba, 272‑8513, Japan.
⁴ Saitama International Headache Center, Saitama, Japan.

No abstract available

Publication types

Published Erratum